TRIM24 | tripartite motif containing 24 | 7q32-q34 | 0.324 | 0.553 | 0
|
TAF4 | TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa | 20q13.33 | 0.32 | 0.565 | 0
|
MPHOSPH10 | M-phase phosphoprotein 10 (U3 small nucleolar ribonucleoprotein) | 2p13.3 | 0.315 | 0.467 | 0
|
EPB41 | erythrocyte membrane protein band 4.1 | 1p33-p32 | 0.312 | 0.475 | 0
|
TET3 | tet methylcytosine dioxygenase 3 | 2p13.1 | 0.31 | 0.564 | 0
|
GRHL2 | grainyhead-like transcription factor 2 | 8q22.3 | 0.309 | 0.388 | 0
|
ZBTB8B | zinc finger and BTB domain containing 8B | 1p35.1 | 0.301 | 0.522 | 0
|
TRIM45 | tripartite motif containing 45 | 1p13.1 | 0.301 | 0.491 | 0
|
CBFA2T2 | core-binding factor, runt domain, alpha subunit 2; translocated to, 2 | 20q11.22 | 0.301 | 0.472 | 0
|
SETD5 | SET domain containing 5 | 3p25.3 | 0.3 | 0.437 | 0
|
PAXBP1 | PAX3 and PAX7 binding protein 1 | 21q22.11 | 0.299 | 0.515 | 0
|
SS18L1 | synovial sarcoma translocation gene on chromosome 18-like 1 | 20q13.3 | 0.298 | 0.537 | 0
|
ZNF761 | zinc finger protein 761 | 19q13.42 | 0.296 | 0.558 | 0
|
VASH2 | vasohibin 2 | 1q23 | 0.294 | 0.386 | 6.45e-20
|
GABBR2 | gamma-aminobutyric acid (GABA) B receptor, 2 | 9q22.1-q22.3 | 0.294 | 0.404 | 0
|
SASS6 | SAS-6 centriolar assembly protein | 1p21.3 | 0.292 | 0.545 | 0
|
CEP250 | centrosomal protein 250kDa | 20q11.22 | 0.291 | 0.518 | 0
|
CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | 19q13.1 | 0.29 | 0.48 | 0
|
CEBPA-AS1 | CEBPA antisense RNA 1 (head to head) | 19q13.11 | 0.29 | 0.439 | 0
|
LOC148709 | | | 0.29 | 0.494 | 0
|
WNT8B | wingless-type MMTV integration site family, member 8B | 10q24 | 0.29 | 0.381 | 2.02e-16
|
PCDHGC3 | protocadherin gamma subfamily C, 3 | 5q31 | 0.289 | -0.473 | 0
|
MITF | microphthalmia-associated transcription factor | 3p14.1-p12.3 | 0.28 | -0.438 | 0
|
ANKRD23 | ankyrin repeat domain 23 | 2q11.2 | 0.28 | 0.462 | 0
|
HOOK1 | hook microtubule-tethering protein 1 | 1p32.1 | 0.278 | 0.475 | 0
|
TUG1 | taurine up-regulated 1 (non-protein coding) | 22q12.2 | 0.277 | 0.389 | 0
|
CASP4 | caspase 4, apoptosis-related cysteine peptidase | 11q22.2-q22.3 | 0.277 | -0.456 | 0
|
CDIP1 | cell death-inducing p53 target 1 | 16p13.3 | 0.276 | -0.485 | 0
|
GXYLT1 | glucoside xylosyltransferase 1 | 12q12 | 0.275 | 0.41 | 0
|
IFI16 | interferon, gamma-inducible protein 16 | 1q22 | 0.275 | -0.418 | 0
|
MTF2 | metal response element binding transcription factor 2 | 1p22.1 | 0.273 | 0.464 | 0
|
HLA-A | major histocompatibility complex, class I, A | 6p21.3 | 0.273 | -0.397 | 0
|
ATAD5 | ATPase family, AAA domain containing 5 | 17q11.2 | 0.272 | 0.501 | 0
|
EPB41L4B | erythrocyte membrane protein band 4.1 like 4B | 9q22.1-q22.3 | 0.272 | 0.453 | 0
|
TNIP1 | TNFAIP3 interacting protein 1 | 5q32-q33.1 | 0.271 | -0.457 | 0
|
MYCN | v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog | 2p24.3 | 0.271 | 0.453 | 0
|
ZNF833P | zinc finger protein 833, pseudogene | 19p13.2 | 0.269 | 0.444 | 0
|
MVP | major vault protein | 16p11.2 | 0.268 | -0.467 | 0
|
TMEM254-AS1 | TMEM254 antisense RNA 1 | 10q22.3 | 0.266 | 0.495 | 0
|
STK10 | serine/threonine kinase 10 | 5q35.1 | 0.265 | -0.357 | 3.5e-14
|
CCDC18 | coiled-coil domain containing 18 | 1p22.1 | 0.264 | 0.382 | 1.03e-16
|
ORC6 | origin recognition complex, subunit 6 | 16q12 | 0.264 | 0.393 | 0
|
HLA-H | major histocompatibility complex, class I, H (pseudogene) | 6p21.3 | 0.263 | -0.366 | 6.24e-15
|
SEPT3 | septin 3 | 22q13.2 | 0.263 | 0.435 | 0
|
COMMD7 | COMM domain containing 7 | 20q11 | 0.262 | 0.441 | 0
|
XYLB | xylulokinase homolog (H. influenzae) | 3p22-p21.3 | 0.262 | 0.479 | 0
|
MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 1q32 | 0.262 | -0.43 | 0
|
CFH | complement factor H | 1q32 | 0.262 | -0.515 | 0
|
LRP10 | low density lipoprotein receptor-related protein 10 | 14q11.2 | 0.262 | -0.414 | 0
|
ESPL1 | extra spindle pole bodies like 1, separase | 12q13.13 | 0.261 | 0.445 | 0
|
TLR4 | toll-like receptor 4 | 9q33.1 | 0.261 | -0.381 | 1.9e-16
|
ZNF878 | zinc finger protein 878 | 19p13.2 | 0.259 | 0.389 | 0
|
TOR4A | torsin family 4, member A | 9q34.3 | 0.259 | -0.389 | 0
|
C2orf68 | chromosome 2 open reading frame 68 | 2p11.2 | 0.259 | 0.432 | 0
|
THAP9 | THAP domain containing 9 | 4q21.3 | 0.258 | 0.377 | 6.09e-16
|
ADAM28 | ADAM metallopeptidase domain 28 | 8p21.2 | 0.258 | -0.437 | 0
|
PPY2P | pancreatic polypeptide 2, pseudogene | 17q11.2 | 0.257 | 0.376 | 7e-16
|
SAPCD2 | suppressor APC domain containing 2 | 9q34.3 | 0.257 | 0.469 | 0
|
PGLYRP2 | peptidoglycan recognition protein 2 | 19p13.12 | 0.256 | 0.313 | 4.92e-11
|
WSB1 | WD repeat and SOCS box containing 1 | 17q11.2 | 0.255 | 0.384 | 5.16e-17
|
CBX2 | chromobox homolog 2 | 17q25.3 | 0.254 | 0.378 | 4.44e-16
|
BLM | Bloom syndrome, RecQ helicase-like | 15q26.1 | 0.253 | 0.436 | 0
|
LSM14B | LSM family member 14B | 20q13.33 | 0.252 | 0.467 | 0
|
FAM72A | family with sequence similarity 72, member A | 1q32.1 | 0.252 | 0.338 | 9.75e-13
|
C10orf54 | chromosome 10 open reading frame 54 | 10q22.1 | 0.251 | -0.466 | 0
|
POLQ | polymerase (DNA directed), theta | 3q13.3 | 0.251 | 0.438 | 0
|
HINT1 | histidine triad nucleotide binding protein 1 | 5q31.2 | 0.251 | -0.389 | 0
|
MAPRE1 | microtubule-associated protein, RP/EB family, member 1 | 20q11.1-q11.3 | 0.249 | 0.313 | 4.82e-11
|
SPAG5 | sperm associated antigen 5 | 17q11.2 | 0.248 | 0.402 | 0
|
TTC7B | tetratricopeptide repeat domain 7B | 14q32.12 | 0.247 | 0.405 | 0
|
GTPBP3 | GTP binding protein 3 (mitochondrial) | 19p13.2 | 0.247 | 0.361 | 1.65e-14
|
DDX52 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 52 | 17q12 | 0.246 | 0.379 | 3.77e-16
|
ARHGAP8 | Rho GTPase activating protein 8 | 22q13.3 | 0.245 | 0.419 | 0
|
SDCBP | syndecan binding protein (syntenin) | 8q12.1 | 0.245 | -0.361 | 1.94e-14
|
BMF | Bcl2 modifying factor | 15q14 | 0.244 | 0.289 | 1.42e-09
|
ZNF341 | zinc finger protein 341 | 20q11.22 | 0.244 | 0.449 | 0
|
TEFM | transcription elongation factor, mitochondrial | 17q11.2 | 0.243 | 0.356 | 4.63e-14
|
ADAM11 | ADAM metallopeptidase domain 11 | 17q21.3 | 0.242 | 0.344 | 3.79e-13
|
TTI1 | TELO2 interacting protein 1 | 20q11.23 | 0.242 | 0.497 | 0
|
ZGRF1 | zinc finger, GRF-type containing 1 | 4q25 | 0.242 | 0.426 | 0
|
MIS18A | MIS18 kinetochore protein A | 21q22.11 | 0.241 | 0.497 | 0
|
GCNT2 | glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) | 6p24.2 | 0.24 | -0.361 | 1.9e-14
|
SMTNL2 | smoothelin-like 2 | 17p13.2 | 0.239 | 0.214 | 8.8e-06
|
GGCT | gamma-glutamylcyclotransferase | 7p15-p14 | 0.239 | 0.425 | 0
|
C1orf112 | chromosome 1 open reading frame 112 | 1q24.2 | 0.239 | 0.419 | 0
|
RAB34 | RAB34, member RAS oncogene family | 17q11.2 | 0.239 | -0.289 | 1.33e-09
|
SQLE | squalene epoxidase | 8q24.1 | 0.239 | 0.379 | 3.75e-16
|
DMBX1 | diencephalon/mesencephalon homeobox 1 | 1p34.1 | 0.238 | 0.426 | 0
|
TSKU | tsukushi, small leucine rich proteoglycan | 11q13.5 | 0.238 | -0.298 | 4.08e-10
|
CABLES2 | Cdk5 and Abl enzyme substrate 2 | 20q13.33 | 0.237 | 0.442 | 0
|
SLC12A8 | solute carrier family 12, member 8 | 3q21.2 | 0.235 | 0.063 | 0.192
|
FAXDC2 | fatty acid hydroxylase domain containing 2 | 5q31-q32 | 0.235 | -0.375 | 8.89e-16
|
ASXL1 | additional sex combs like transcriptional regulator 1 | 20q11 | 0.235 | 0.372 | 1.78e-15
|
LIG3 | ligase III, DNA, ATP-dependent | 17q11.2-q12 | 0.234 | 0.409 | 0
|
NFS1 | NFS1 cysteine desulfurase | 20q11.22 | 0.233 | 0.399 | 0
|
C18orf54 | chromosome 18 open reading frame 54 | 18q21 | 0.233 | 0.4 | 0
|
DDX55 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 55 | 12q24.31 | 0.233 | 0.429 | 0
|
ZNF695 | zinc finger protein 695 | 1q44 | 0.232 | 0.474 | 0
|
CDK2 | cyclin-dependent kinase 2 | 12q13 | 0.232 | 0.465 | 0
|
FCER1A | Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide | 1q23 | 0.227 | -0.333 | 2.17e-12
|
THSD4 | thrombospondin, type I, domain containing 4 | 15q23 | 0.227 | -0.353 | 7.1e-14
|
MPP2 | membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) | 17q12-q21 | 0.225 | 0.325 | 7.85e-12
|
HSD11B2 | hydroxysteroid (11-beta) dehydrogenase 2 | 16q22 | 0.225 | 0.397 | 0
|
BTF3 | basic transcription factor 3 | 5q13.3 | 0.225 | -0.334 | 1.79e-12
|
CTSO | cathepsin O | 4q32.1 | 0.223 | -0.35 | 1.23e-13
|
GNB3 | guanine nucleotide binding protein (G protein), beta polypeptide 3 | 12p13 | 0.222 | 0.217 | 6.12e-06
|
HIST2H3C | histone cluster 2, H3c | 1q21.2 | 0.222 | 0.36 | 2.02e-14
|
HAUS5 | HAUS augmin-like complex, subunit 5 | 19q13.12 | 0.221 | 0.407 | 0
|
SDCCAG8 | serologically defined colon cancer antigen 8 | 1q43 | 0.219 | -0.321 | 1.41e-11
|
TMSB15A | thymosin beta 15a | Xq21.33-q22.3 | 0.219 | 0.182 | 0.000157
|
ADCY1 | adenylate cyclase 1 (brain) | 7p12.3 | 0.218 | 0.294 | 7.41e-10
|
ASAP3 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 | 1p36.13 | 0.218 | 0.269 | 1.78e-08
|
DHTKD1 | dehydrogenase E1 and transketolase domain containing 1 | 10p14 | 0.218 | 0.445 | 0
|
MSH5 | mutS homolog 5 | 6p21.3 | 0.216 | 0.328 | 4.55e-12
|
ANTXR2 | anthrax toxin receptor 2 | 4q21.3 | 0.215 | -0.402 | 0
|
ACTR5 | ARP5 actin-related protein 5 homolog (yeast) | 20q12 | 0.215 | 0.386 | 6.67e-19
|
SEC61A2 | Sec61 translocon alpha 2 subunit | 10p14 | 0.214 | 0.408 | 0
|
SALL4 | spalt-like transcription factor 4 | 20q13.2 | 0.212 | 0.415 | 0
|
TK2 | thymidine kinase 2, mitochondrial | 16q22-q23.1 | 0.212 | -0.37 | 2.74e-15
|
CCNF | cyclin F | 16p13.3 | 0.211 | 0.39 | 0
|
EEF1A1 | eukaryotic translation elongation factor 1 alpha 1 | 6q14.1 | 0.21 | -0.389 | 0
|
PNPLA6 | patatin-like phospholipase domain containing 6 | 19p13.2 | 0.21 | -0.212 | 1.01e-05
|
KCNQ1OT1 | KCNQ1 opposite strand/antisense transcript 1 (non-protein coding) | 11p15.5 | 0.21 | 0.239 | 6.19e-07
|
RIMS2 | regulating synaptic membrane exocytosis 2 | 8q22.3 | 0.209 | -0.219 | 5.38e-06
|
SIGLEC16 | sialic acid binding Ig-like lectin 16 (gene/pseudogene) | 19q13.33 | 0.208 | -0.22 | 4.64e-06
|
PDRG1 | p53 and DNA-damage regulated 1 | 20q11.21 | 0.207 | 0.394 | 0
|
DUSP22 | dual specificity phosphatase 22 | 6p25.3 | 0.206 | -0.374 | 1.31e-15
|
CDK5RAP1 | CDK5 regulatory subunit associated protein 1 | 20q11.21 | 0.206 | 0.389 | 0
|
RUFY1 | RUN and FYVE domain containing 1 | 5q35.3 | 0.204 | -0.364 | 9.02e-15
|
AQP11 | aquaporin 11 | 11q13.5 | 0.204 | 0.342 | 4.79e-13
|
TM2D2 | TM2 domain containing 2 | 8p11.23 | 0.199 | -0.22 | 4.71e-06
|
TNFRSF10D | tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain | 8p21 | 0.199 | -0.345 | 2.89e-13
|
ERGIC1 | endoplasmic reticulum-golgi intermediate compartment 1 | 5q35.1 | 0.198 | -0.367 | 6.01e-15
|
SNX19 | sorting nexin 19 | 11q25 | 0.197 | -0.334 | 1.97e-12
|
HIST2H2BE | histone cluster 2, H2be | 1q21.2 | 0.195 | 0.298 | 4.33e-10
|
DKFZp434J0226 | | | 0.193 | 0.33 | 3.28e-12
|
HSF2BP | heat shock transcription factor 2 binding protein | 21q22.3 | 0.191 | 0.275 | 9.09e-09
|
SLC23A1 | solute carrier family 23 (ascorbic acid transporter), member 1 | 5q31.2 | 0.19 | 0.279 | 5e-09
|
HIST1H4E | histone cluster 1, H4e | 6p22.2 | 0.189 | 0.357 | 3.81e-14
|
LGALS3BP | lectin, galactoside-binding, soluble, 3 binding protein | 17q25 | 0.189 | -0.222 | 3.78e-06
|
MYOM2 | myomesin 2 | 8p23.3 | 0.189 | -0.36 | 2.23e-14
|
MGME1 | mitochondrial genome maintenance exonuclease 1 | 20p11.23 | 0.187 | 0.315 | 3.26e-11
|
PALMD | palmdelphin | 1p21.2 | 0.187 | -0.121 | 0.0125
|
RPSAP9 | ribosomal protein SA pseudogene 9 | 9q21.13 | 0.186 | -0.021 | 0.659
|
C20orf196 | chromosome 20 open reading frame 196 | 20p12.3 | 0.185 | 0.062 | 0.197
|
SOGA1 | suppressor of glucose, autophagy associated 1 | 20q11.23 | 0.175 | 0.212 | 1.03e-05
|
CNKSR3 | CNKSR family member 3 | 6q25.2 | 0.173 | -0.193 | 6.1e-05
|